Purchase Order N0017316P1620
- Not listed
- The Office of Naval Research awarded a firm fixed-price purchase order valued at $13,220 to Bio-Synthesis, Inc. (doing business as Dnaexam) on February 6, 2017, with an ultimate completion date of March 8, 2017. The contract, registered under PR# 69-4143-17, was issued without a set-aside designation and covers biologicals to be delivered to Lewisville, Texas. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of specialized biological research materials headquartered in Lewisville,...
- The Office of Naval Research (ONR) awarded a $3,400 purchase order to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer specializing in custom peptide synthesis and advanced biological research materials. The firm fixed price contract, issued on January 15, 2014, with an ultimate completion date of February 5, 2014, was performed at Bio-Synthesis's facility in Lewisville, Texas. No set-aside designation was utilized for this award. Bio-Synthesis, Inc., which operates under the trade...
- The Office of Naval Research (ONR) awarded a $4,410 firm fixed-price purchase order to Bio-Synthesis, Inc. on February 24, 2016, for biologicals, with performance completion targeted for March 23, 2016. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in custom synthesis of advanced biological research materials including peptides, RNA, and nucleic acid products. No set-aside designation was applied to...
- The Office of Naval Research (ONR) awarded a $3,655 firm fixed-price purchase order to Bio-Synthesis, Inc. for custom peptides, with an ultimate completion date of April 25, 2013. The award, issued on March 26, 2013, was not structured under any set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, specializes in advanced biological research materials and custom synthesis services, including peptide and nucleic acid production for...
- The Office of Naval Research awarded a $4,375 purchase order to Bio-Synthesis, Inc. for custom CECA peptide synthesis services. The contract, issued on May 29, 2014, with an ultimate completion date of June 23, 2014, represents a firm fixed-price engagement with no set-aside designation. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, and operating under the trade name Dnaexam, specializes in advanced biological research materials and custom molecular...
- This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Bio-Synthesis, Inc., a Hispanic American-owned small business. The contract is for custom peptide synthesis services, with a ceiling value of $3,259.00 and an ultimate completion date of February 25, 2015. The contract was awarded on February 18, 2015 and did not use a set-aside....
- <p>The National Institute of Allergy and Infectious Diseases awarded a purchase order to Bio-Synthesis, Inc. for chemical RNA ubermers and RNA transcription synthesis, valued at $5,210.00, with an award date of March 21, 2018 and completion date of March 20, 2019. Work is performed in Lewisville, Texas. Bio-Synthesis, Inc. is a Hispanic American-owned manufacturer of biological research materials.</p>
- This federal contract award, with the ID HHSN272201200589P, was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Bio-Synthesis, Inc. (doing business as Dnaexam), a for-profit, Hispanic American-owned manufacturer. The contract, with a firm fixed price of $5,565.00, is for the delivery of drugs and biologicals. The contract does not have a set-aside designation and was awarded on July 18, 2012, with a...
- This is a $10,585.00 firm fixed price purchase order awarded by the National Heart Lung and Blood Institute, a civilian agency, to Bio-Synthesis, Inc., a Hispanic American-owned manufacturer of goods. The contract is for the delivery of stapled NIX-derived peptides with derivatized N-termini to support the agency's ongoing study of the NIX/WIPI protein interaction, which began in March 2023. The award does not utilize a set-aside designation, and the ultimate completion date is June 24, 2025.
- <p>The Office of Naval Research issued a purchase order to Genscript USA Inc. valued at $4,444.42 on April 6, 2017, for peptide synthesis services. Work is performed in Piscataway, New Jersey, with an ultimate completion date of May 31, 2017. The order is firm fixed price with no small business set-aside.</p>
The Office of Naval Research awarded a $3,855 firm fixed-price purchase order to Bio-Synthesis, Inc. (doing business as Dnaexam) on June 14, 2016, for custom DNA peptide synthesis. The contract, with an ultimate completion date of July 18, 2016, represents a straightforward procurement of specialized biological research materials. Bio-Synthesis, Inc., a Hispanic American-owned manufacturer based in Lewisville, Texas, specializes in advanced molecular synthesis services including peptides, RNA, and nucleic acids for federal research institutions. The contract was not subject to any set-aside designation. Bio-Synthesis, Inc. has demonstrated sustained technical capacity in delivering high-quality custom molecular research materials to federal agencies, with a track record of awards from the National Heart Lung and Blood Institute, National Institute of Allergy and Infectious Diseases, and National Institute on Drug Abuse. The company's expertise in producing complex biological materials aligns with the Office of Naval Research's mission-oriented research needs, where custom peptide synthesis supports scientific investigations across biomedical domains relevant to naval and defense research priorities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 6/13/16 |